• Data Storage Checklist

    Computerworld | Data storage is an ever present question and concern for many companies. Computerworld breaks out 14 points to consider as you build a data storage plan.

    Sep 11, 2013

  • Harvard, MIT Get NSF Grant for Artificial Intelligence Research

    Computerworld | Harvard and MIT have been awarded $25 million in NSF grant money to work on artificial intelligence. Researchers will study how the brain creates intelligence and how that process can be replicated in machines.

    Sep 11, 2013

  • Bayer, Broad Sign Oncogenomics Partnership

    Bio-IT World  | Bayer HealthCare and the Broad Institute have announced a strategic alliance in oncogenomics and drug discovery in order to jointly discover and develop therapeutic agents that selectively target cancer genome alterations over a period of five years.

    Sep 10, 2013

  • Chemistry Compendium

    Chemical & Engineering News | As part of its 90th Anniversary issue, Chemical & Engineering News highlighted nine areas of chemistry that had a profound effect on the planet including antibiotics, computational chemistry, and structural biology.

    Sep 10, 2013

  • Amicus, Biogen Sign Deal for Parkinson's Disease

    Xconomy | Amicus Therapeutics and Biogen Idec announced a deal today to discover, develop and commercialize small molecule drugs for Parkinson's Disease.

    Sep 10, 2013

  • Isis and Biogen Sign Six Year Collaboration

    Bloomberg Businessweek | Isis Pharmaceuticals signed a six-year agreement with Biogen Idec to develop new therapies to treat neurological disorders.

    Sep 9, 2013

  • Lasker Awards to Five Scientists, Bill and Melinda Gates

    New York Times | The Albert and Mary Lasker Foundation awards were announced today. Winners include three scientists who helped deaf people to hear, two for their work in neurotransmission, and Bill and Melinda Gates for their public service work.

    Sep 9, 2013

  • Right to Ignorance

    New Scientist | Do we have the right to ignorance? Opinions have been swirling around the disclosure aspect of genetic data, and an article in New Scientist argues that we have the right to choose ignorance.

    Sep 6, 2013

  • Natera, Illumina Renew Prenatal Diagnostics Partnership

    Bio-IT World | Natera and Illumina entered a three-year agreement yesterday dictating that Illumina will supply Natera with the HiSeq 2500 sequencing system and associated consumables for Natera’s Panorama noninvasive prenatal test (NIPT).

    Sep 5, 2013

  • Protein Sound and Light Show

    Scientific American | Researchers at the University of Chicago have built the first biotech musical instrument. The instrument relies on proteins from plants that respond to sunlight.

    Sep 4, 2013

  • ImClone's Sam Waksal has IPO Plans

    Bloomberg | ImClone's Sam Waksal is making biotech plans again. Hoping to cash in on biotech's current success, Waksal is planning to spin out two units of his Kadmon Corp.

    Sep 4, 2013

  • Orally-Delivered Syringes

    In the Pipeline | Google is always up for a long shot, and Google Ventures is backing another one. A small biotech is working on a way to orally deliver large protein drugs.

    Sep 3, 2013

  • Eagle Genomics Raises Funds to Complete, Launch SaaS Platform

    Business Weekly | Eagle Genomics completed a funding round worth more than $926,000 (GBP 595,000). The number puts the group a bit more than halfway to its goal.

    Sep 3, 2013

  • Smithsonian's Genome Exhibit

    New York Times | The Smithsonian's "Genome: Unlocking Life's Code" exhibit has been open all summer. Three months in, the New York Times looks at what has succeeded and what has fallen short in the, "smart, playful, and... enlightening" exhibit.

    Aug 30, 2013

  • MIT's 110-Core Chip

    Computerworld | MIT researchers have developed a 110-core chip while looking for power-efficient ways to boost performance in mobile devices.

    Aug 30, 2013

  • Pharma Ventures

    Wall Street Journal Blogs | Pharma is getting more notice from venture capital these days. Clarus Ventures, for example, has backed three specific pharma projects including Phase III studies of an already-approved drug in a new indication.

    Aug 30, 2013

  • BGI's Plans for Complete Genomics, Planned IPO

    Forbes Asia | Forbes Asia checks in with BGI since their Complete Genomics acquisition. The group is readying an IPO of their institutional-client business, and have sequenced 57,000 human genomes to date.

    Aug 29, 2013

  • The Coming Bust?

    Nature | It's been a great year for biotech IPOs, which has everyone wondering when the bubble will burst. In 2000 there were 26 biotech IPOs, but 2001 and 2002 showed almost no revenue from biotech IPOs.

    Aug 29, 2013

  • Behind Third Rock

    Boston Magazine | Third Rock Ventures invests heavily in biotech, now taking on projects for "ultra-orphan" diseases. Though the risks are high, the rewards are too. A recent acquisition could could net Third Rock a 20-fold payout for their investment.

    Aug 28, 2013

  • Far Off Genomics: FarGen 2013

    Bio-IT World | In the high north, the tiny Faroese population has been isolated—physically and genetically—for more than 1,000 years. Now the FarGen Project will be offering whole genome sequencing to all 50,000 inhabitants of the Faroe Islands.

    Aug 28, 2013